Theranostics 2022; 12(1):421. doi:10.7150/thno.68830 This issue Cite

Erratum

Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum

Haoran Liu1,2*, Xiaoqi Yang1*, Kun Tang1, Tao Ye1, Chen Duan1, Peng Lv1, Libin Yan1, Xiaoliang Wu1, Zhiqiang Chen1, Jianhe Liu2, Yaoliang Deng3, Guohua Zeng4, Jinchun Xing5, Zhangqun Ye1, Hua Xu1✉

1. Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
2. Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
3. Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
4. Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
5. Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
*These authors contributed equally to this work.

Citation:
Liu H, Yang X, Tang K, Ye T, Duan C, Lv P, Yan L, Wu X, Chen Z, Liu J, Deng Y, Zeng G, Xing J, Ye Z, Xu H. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum. Theranostics 2022; 12(1):421. doi:10.7150/thno.68830. https://www.thno.org/v12p0421.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 10, 7319


Citation styles

APA
Liu, H., Yang, X., Tang, K., Ye, T., Duan, C., Lv, P., Yan, L., Wu, X., Chen, Z., Liu, J., Deng, Y., Zeng, G., Xing, J., Ye, Z., Xu, H. (2022). Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum. Theranostics, 12(1), 421. https://doi.org/10.7150/thno.68830.

ACS
Liu, H.; Yang, X.; Tang, K.; Ye, T.; Duan, C.; Lv, P.; Yan, L.; Wu, X.; Chen, Z.; Liu, J.; Deng, Y.; Zeng, G.; Xing, J.; Ye, Z.; Xu, H. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum. Theranostics 2022, 12 (1), 421. DOI: 10.7150/thno.68830.

NLM
Liu H, Yang X, Tang K, Ye T, Duan C, Lv P, Yan L, Wu X, Chen Z, Liu J, Deng Y, Zeng G, Xing J, Ye Z, Xu H. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum. Theranostics 2022; 12(1):421. doi:10.7150/thno.68830. https://www.thno.org/v12p0421.htm

CSE
Liu H, Yang X, Tang K, Ye T, Duan C, Lv P, Yan L, Wu X, Chen Z, Liu J, Deng Y, Zeng G, Xing J, Ye Z, Xu H. 2022. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum. Theranostics. 12(1):421.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image